CN Patent

CN101932238A — 使用半胱胺制品治疗非酒精性脂肪性肝炎(nash)的方法

Assigned to University of California San Diego UCSD · Expires 2010-12-29 · 15y expired

What this patent protects

本发明公开一般涉及脂肪肝病症的治疗，包括施用包含半胱胺制品的组合物。本发明公开提供肠溶衣半胱胺组合物的施用以治疗脂肪肝病症，例如非酒精性脂肪肝疾病(NAFLD)和非酒精性脂肪性肝炎(NASH)。

USPTO Abstract

本发明公开一般涉及脂肪肝病症的治疗，包括施用包含半胱胺制品的组合物。本发明公开提供肠溶衣半胱胺组合物的施用以治疗脂肪肝病症，例如非酒精性脂肪肝疾病(NAFLD)和非酒精性脂肪性肝炎(NASH)。

Drugs covered by this patent

cysteamine-bitartrate (CYSTEAMINE BITARTRATE)

Patent Metadata

Patent number: CN101932238A
Jurisdiction: CN
Classification: —
Expires: 2010-12-29
Drug substance claim: No
Drug product claim: No
Assignee: University of California San Diego UCSD
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.